Overview Fundamentals API Earnings EOD API Sample Code Pricing

BerGenBio ASA (BRRGF PINK) stock market data APIs

$2.5 0(0%) as of June 13, 2024
Price chart is built with Anychart

BerGenBio ASA, a clinical-stage biopharmaceutical company, engages in the development of medicines to treat drug resistant, metastatic cancers, and respiratory diseases in Norway. The company's lead clinical asset is the Bemcentinib (BGB016), an inhibitor of AXL receptor tyrosine kinase (AXL), which is in phase 1b/2a clinical trial to treat non-small cell lung cancer; and (BGBC008), which is in phase 2 clinical trial to treat second-line non-small cell lung cancer (2L NSCLC). It also develops Bemcentinib, which is in preclinical trial to treat acute respiratory distress syndrome; Tilvestamab (BGB149), anti-AXL monoclonal antibody, which in phase 1 clinical trial for the treatment of ovarian cancer; and Mipasetamab Uzoptirine, which is in Phase 1 clinical trial for the treatment of solid tumors. BerGenBio ASA was incorporated in 2007 and is based in Bergen, Norway.

BerGenBio ASA Financial Data Overview

977 K
39 087 K
521 K
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'BRRGF',
Type: 'Common Stock',
Name: 'BerGenBio ASA',
Exchange: 'PINK',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG00LGDWPB4',
EmployerIdNumber: '',
FiscalYearEnd: 'December',
InternationalDomestic: 'Domestic',
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: NULL,
IsDelisted: false,

BerGenBio ASA Fundamental Data is available in our Financial Data APIs

  • Net Revenue 521 K
  • EBITDA -159 042 000
  • Earnings Per Share -5.26
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get BerGenBio ASA Earnings via APIs

  • Latest Release 2024-05-29
  • EPS/Forecast NaN

Get BerGenBio ASA End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?